Dermal Fillers Market

Dermal Fillers Market: Overview

The Dermal Fillers Market is valued at USD 5.7 Bn in 2026 and is projected to reach USD 11 Bn, growing at a CAGR of 10% by 2033. Because of different developments in the improving aesthetic and rejuvenating improvements that were previously only possible with surgeries, the use of dermal fillers has increased significantly in recent years. These techniques for face rejuvenation are rising in popularity. Dermal fillers exhibit immediate benefits in cosmetic volume replacement procedures due to their less invasive nature. These gadgets provide face volume and boost and improve the skin's condition. For augmentation, a variety of techniques, including injections, are performed. For aesthetic reasons, these fillers can produce larger, plumper lips. Depending on the substance utilized, there are numerous types of dermal fillers that can be injected into the lips and the area surrounding the mouth to maintain the volume of the lips.

Increased Internet usage both in developed and developing nations gives consumers the chance to investigate the several dermal filler treatments that are available to treat skin and facial disorders, which increases online sales. Dermal filler techniques employ a variety of dermal filler types for various objectives. For instance, face fillers are used to improve the look of facial lines, whereas soft tissue fillers are used to smooth skin and reduce the prominence of wrinkles. Injected into the skin, facial fillers smooth out wrinkles and hide their appearance. Due to the rise in awareness of social media, the benefits of product comparison increased desire to keep young looks, and growth in the anti-aging fad all contribute to the expansion of the market.

Manufacturers are investing significantly in research and development (R&D) to create novel and cutting-edge technologies in the realm of cosmetics. Higher quality fillers are now being developed as a result, which will make them simpler to use and improve patient satisfaction. Long used as dermal fillers, cross-linked hyaluronic acid generated from non-animal sources has been shown to be both safe and efficient. The market for dermal fillers will develop as a result of new formulations being introduced by some of the top manufacturers. For instance, the Swedish business Bohus Biotech created an enhanced dermal filler formulation using spherification technology, replacing the conventional structure with smooth, spherical particles.  Fewer operations are required because of the high stability and longevity of these more recent product compositions.

Dermal Fillers Market: COVID-19 Impact

The coronavirus outbreak is anticipated to have a detrimental effect on the global market for dermal fillers. In 2020, the market had a 40% decline from 2019. The lockdown that was imposed on a global front resulted in the closure of numerous cosmetic facilities and clinics. The number of cosmetic procedures is declining due to the rising incidence of coronavirus, which has a detrimental effect on the size of the dermal fillers industry.

Increasing Use of Less Invasive Methods to Drive Market Growth

In contrast to conventional treatments for aesthetic and cosmetic surgery, including laser and other energy-based equipment, the usage of minimally invasive procedures has increased. Specially constructed devices have been created for minimally invasive surgical and non-surgical operations. By rejuvenating and tightening the skin, these anti-aging gadgets aid in minimising the visible symptoms of skin ageing and impart a youthful appearance. A scope for seeing and surgical instruments with specialised equipment are used in minimally invasive surgery. It reduces volume, shape, and undesirable fat while concentrating on the abnormalities of the face, such as wrinkles and fine lines. The use of minimally invasive techniques is becoming more popular because they have almost no risk of significant adverse outcomes and need few or no cuts with quick recovery. There is a huge demand worldwide for energy-based, minimally invasive procedures for skin tightening, wrinkle reduction, face contouring, and skin rejuvenation. Other factors driving demand for these operations include an ageing population and an increase in the need for healthcare facilities, both of which can lessen the pressure on those facilities.

Rising Geriatric Population Driving Market Growth

The geriatric population is growing due to higher life expectancies, and it has been noted that skin aging problems are getting worse. While the world's population is aging at an exponential rate, European nations have a number of comparable cultural, social, and economic traits and ambitions. As people begin to age, their desire to look younger grows, which eventually sparks interest in using aesthetic procedures. Better patient outcomes have been achieved as healthcare delivery has improved and the population of elderly persons has increased in Middle Eastern nations.

High Cost and Lack of Skilled Professionals to Hamper Market Growth

The cost of an elective operation is always taken into account. The type of dermal filler and the quantity utilized in the procedure determine the price. Additionally, the cost of the procedure depends on the training and experience of the individual administering the dermal fillers. Dermal filler cosmetic therapy is a popular and safe outpatient procedure for treating some indications of aging and volume loss, but the market demand is anticipated to be hampered by the high cost of the operations. Additionally, there are other types of aesthetic treatment methods, including laser-based technology, energy-based technology, and powerful pulse light, to name a few. For any of these strategies to be used effectively, the practitioner must possess strong interpersonal skills. Moreover, the field's rapid technological development has resulted in a shortage of qualified specialists. When handling devices and performing surgical operations, a lack of competent experts is a significant challenge.

Dermal Fillers Market: Segment Overview

Multispecialty Hospitals to Dominate Market due to Demand for Operations in Hospitals

In 2021, the hospitals sector led the global market in terms of end-user. Throughout the predicted period, it is anticipated that this tendency would persist. The hospitals segment is expected to grow throughout the projected period due to an increase in patient demand for dermal filler operations in hospitals. However, due to the rise in the number of dermatology clinics, the number of dermatological consultations, and the rise in patient demand for treatment by a specialist dermatologist, the dermatology clinics sector is predicted to grow at a higher CAGR over the projected period.

With Increased Interest in Looking Young, Facial Line Correction Treatment Category Dominated Market

In 2021, the facial line correction application category dominated the global market. The market is predicted to expand at a rapid CAGR over the forecast period. The increase in interest in looking young and the focus on correcting facial volume loss and dynamic lines can be attributed to the segment's growth. The launch of Radiesse filler, an injectable filler used to fill in wrinkled or folded skin, most frequently on the face, is one of the key factors driving the dermal fillers industry.

North America to Dominate Market due to Growing Preference for Online Grocery Shopping

Throughout the projected period, North America will continue to be one of the most attractive markets for dermal fillers. The region's high disposable income, good ability to spend on cosmetic operations, the presence of top manufacturers, and the expanding demand for non-surgical procedures in the region are some of the main drivers promoting expansion. The Centers for Medicare & Medicaid Services (CMS) Office of the Actuary has made early predictions that the country's total healthcare spending will rise at a rate of 5.4% between 2022 and 2028, surpassing the GDP by 4.3%. According to the American Society of Plastic Surgeons (ASPS), 16.3 million Americans got minimally invasive cosmetic operations in 2019. This is roughly a quarter of a million more procedures than in 2018. 5.9 million reconstructive procedures are performed. A favourable environment has been established for the market in the United States by high disposable income and supportive healthcare regulations. Additionally, the existence of major players like Zimmer Biomet Holdings promotes expansion in the United States. These businesses' strategies, which include product releases and expansion plans, will continue to fuel rapid overall growth in the United States.

Due to the rising geriatric population and rising per capita income, APAC is anticipated to expand at the fastest CAGR throughout the projection period. Another significant factor that is anticipated to propel the market in the area during the assessment period is the increased demand for non-invasive cosmetic procedures and products for facial aesthetics. Due to the presence of profitable chances that might accelerate the industry, the presence of growing nations like India, China, and Japan is anticipated to significantly enhance the regional market.  Because of the lack of awareness and the restricted access to facilities, MEA is projected to experience the lowest growth rate. But the region's untapped market potential and the rising number of new product launches in a few Middle Eastern nations are anticipated to expand the industry there. Due to the prevalence of poor countries, the African area is anticipated to lag. Saudi Arabia, Kuwait, and a few other Middle Eastern nations are expected to enhance regional trade, nevertheless.

Galderma disclosed in November 2021 that it has entered a binding contract to buy ALASTIN Skincare, Inc., a specialized aesthetics business specializing in the creation of cutting-edge, clinically-proven, physician-dispensed skincare products. The acquisition is dependent on the required regulatory approvals and customary closing conditions. Moreover, Sinclair Pharma stated in April 2022 that it has gained the European CE mark for its Perfectha Lidocaine wrinkle-reduction, facial contouring, and volume-restoration products. Perfectha Lidocaine is now available in the UK and all major European markets thanks to this CE accreditation.

Few of the players in the Dermal Fillers Market include:

• AbbVie Inc. / Allergan Aesthetics
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA / Merz Aesthetics
• Revance Therapeutics, Inc.
• Sinclair Pharma / Huadong Medicine
• Teoxane Laboratories
• Prollenium Medical Technologies Inc.
• Suneva Medical, Inc.
• BioPlus Co., Ltd.
• Croma-Pharma GmbH
• Laboratoires Vivacy SAS
• LG Chem Ltd.
• Hugel, Inc.
• Medytox Inc.
• Anika Therapeutics, Inc.

The Global Dermal Fillers Market is Segmented as Below:

By Material
• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• PMMA (Poly (Methyl Methacrylate))
• Fat Fillers
• Collagen
• Others

By Product
• Biodegradable
• Non-Biodegradable

By Application
• Scar Treatment
• Wrinkle Correction Treatment
• Lip Enhancement
• Restoration of Volume/Fullness
• Others

By End-user
• Specialty & Dermatology Clinics
• Hospitals & Clinics
• Others

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa